Annual Accounts Receivable
$962.85 M
+$79.99 M+9.06%
31 March 2024
Summary:
Dr Reddys Laboratories Limited annual accounts receivable is currently $962.85 million, with the most recent change of +$79.99 million (+9.06%) on 31 March 2024. During the last 3 years, it has risen by +$286.99 million (+42.46%). RDY annual accounts receivable is now at all-time high.RDY Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$1.01 B
+$36.46 M+3.75%
01 September 2024
Summary:
Dr Reddys Laboratories Limited quarterly accounts receivable is currently $1.01 billion, with the most recent change of +$36.46 million (+3.75%) on 01 September 2024. Over the past year, it has increased by +$170.22 million (+20.31%). RDY quarterly accounts receivable is now at all-time high.RDY Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RDY Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.1% | +20.3% |
| 3 y3 years | +42.5% | +9.2% |
| 5 y5 years | +67.7% | +74.7% |
RDY Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +42.5% | at high | +20.3% |
| 5 y | 5 years | at high | +67.7% | at high | +74.7% |
| alltime | all time | at high | +1777.2% | at high | +1710.6% |
Dr Reddys Laboratories Limited Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.01 B(+3.8%) |
| June 2024 | - | $971.68 M(+0.9%) |
| Mar 2024 | $962.85 M(+9.1%) | $962.85 M(+2.5%) |
| Dec 2023 | - | $939.36 M(+12.1%) |
| Sept 2023 | - | $837.92 M(-10.8%) |
| June 2023 | - | $939.33 M(+6.4%) |
| Mar 2023 | $882.87 M(+0.3%) | $882.87 M(-2.6%) |
| Dec 2022 | - | $906.78 M(-4.0%) |
| Sept 2022 | - | $944.86 M(+1.8%) |
| June 2022 | - | $927.91 M(+5.4%) |
| Mar 2022 | $880.48 M(+30.3%) | $880.48 M(+4.9%) |
| Dec 2021 | - | $838.96 M(-9.1%) |
| Sept 2021 | - | $923.16 M(+12.4%) |
| June 2021 | - | $821.42 M(+21.5%) |
| Mar 2021 | $675.86 M(+1.4%) | $675.86 M(-6.6%) |
| Dec 2020 | - | $723.84 M(+7.1%) |
| Sept 2020 | - | $675.89 M(+9.9%) |
| June 2020 | - | $614.79 M(-7.8%) |
| Mar 2020 | $666.64 M(+16.1%) | $666.64 M(+7.4%) |
| Dec 2019 | - | $620.49 M(+7.5%) |
| Sept 2019 | - | $577.14 M(+5.7%) |
| June 2019 | - | $545.76 M(-4.9%) |
| Mar 2019 | $574.07 M(-8.0%) | $574.07 M(+8.0%) |
| Dec 2018 | - | $531.73 M(-16.4%) |
| Sept 2018 | - | $636.16 M(-8.6%) |
| June 2018 | - | $696.38 M(+11.6%) |
| Mar 2018 | $623.88 M(+6.3%) | $623.88 M(-6.1%) |
| Dec 2017 | - | $664.49 M(+2.9%) |
| Sept 2017 | - | $645.71 M(+1.7%) |
| June 2017 | - | $634.79 M(+8.1%) |
| Mar 2017 | $586.96 M(-5.6%) | $586.96 M(-3.0%) |
| Dec 2016 | - | $605.27 M(+9.5%) |
| Sept 2016 | - | $552.61 M(+5.0%) |
| June 2016 | - | $526.45 M(-15.4%) |
| Mar 2016 | $622.07 M(-4.5%) | $622.07 M(-1.3%) |
| Dec 2015 | - | $630.24 M(-3.0%) |
| Sept 2015 | - | $649.88 M(-1.5%) |
| June 2015 | - | $659.45 M(+1.2%) |
| Mar 2015 | $651.67 M(+18.0%) | $651.67 M(+2.7%) |
| Dec 2014 | - | $634.33 M(+3.5%) |
| Sept 2014 | - | $612.61 M(+1.9%) |
| June 2014 | - | $601.23 M(+8.9%) |
| Mar 2014 | $552.05 M(-6.1%) | $552.05 M(-2.0%) |
| Dec 2013 | - | $563.26 M(+6.5%) |
| Sept 2013 | - | $528.99 M(+9.2%) |
| June 2013 | - | $484.48 M(-17.6%) |
| Mar 2013 | $587.65 M | $587.65 M(+19.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $490.70 M(-0.9%) |
| Sept 2012 | - | $495.02 M(+12.6%) |
| June 2012 | - | $439.56 M(-10.9%) |
| Mar 2012 | $493.35 M(+25.0%) | $493.35 M(-0.8%) |
| Dec 2011 | - | $497.13 M(+18.2%) |
| Sept 2011 | - | $420.62 M(+10.0%) |
| June 2011 | - | $382.30 M(-3.1%) |
| Mar 2011 | $394.58 M(+48.0%) | $394.58 M(+25.6%) |
| Dec 2010 | - | $314.27 M(+5.1%) |
| Sept 2010 | - | $298.95 M(+8.8%) |
| June 2010 | - | $274.79 M(+3.1%) |
| Mar 2010 | $266.59 M(-7.4%) | $266.59 M(+6.6%) |
| Dec 2009 | - | $250.04 M(-9.1%) |
| Sept 2009 | - | $274.94 M(-4.5%) |
| Mar 2009 | $287.90 M(+69.3%) | $287.90 M(+7.3%) |
| Dec 2008 | - | $268.40 M(+20.3%) |
| Sept 2008 | - | $223.17 M(+8.5%) |
| June 2008 | - | $205.63 M(+20.9%) |
| Mar 2008 | $170.10 M(-2.9%) | $170.10 M(-14.0%) |
| Dec 2007 | - | $197.85 M(-6.5%) |
| Sept 2007 | - | $211.60 M(+20.1%) |
| June 2007 | - | $176.16 M(+0.6%) |
| Mar 2007 | $175.09 M(+61.9%) | $175.09 M(+27.6%) |
| Dec 2006 | - | $137.23 M(-35.9%) |
| Sept 2006 | - | $214.25 M(+1.5%) |
| June 2006 | - | $211.06 M(+95.2%) |
| Mar 2006 | $108.12 M(+31.4%) | $108.12 M(+7.8%) |
| Dec 2005 | - | $100.29 M(+1.1%) |
| Sept 2005 | - | $99.18 M(+9.6%) |
| June 2005 | - | $90.50 M(+10.0%) |
| Mar 2005 | $82.26 M(-4.6%) | $82.26 M(-4.1%) |
| Dec 2004 | - | $85.77 M(-4.0%) |
| Sept 2004 | - | $89.34 M(-1.5%) |
| June 2004 | - | $90.73 M(+5.2%) |
| Mar 2004 | $86.27 M(+15.6%) | $86.27 M(-5.4%) |
| Dec 2003 | - | $91.15 M(-1.4%) |
| Sept 2003 | - | $92.46 M(+1.8%) |
| June 2003 | - | $90.79 M(+21.6%) |
| Mar 2003 | $74.64 M(-4.4%) | $74.64 M(-6.5%) |
| Dec 2002 | - | $79.83 M(+1.8%) |
| Sept 2002 | - | $78.41 M(+6.6%) |
| June 2002 | - | $73.53 M(-5.9%) |
| Mar 2002 | $78.11 M(+52.3%) | $78.11 M(-3.2%) |
| Dec 2001 | - | $80.69 M(-12.3%) |
| Sept 2001 | - | $92.00 M(+65.2%) |
| June 2001 | - | $55.68 M |
| Mar 2001 | $51.29 M | - |
FAQ
- What is Dr Reddys Laboratories Limited annual accounts receivable?
- What is the all time high annual accounts receivable for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual accounts receivable year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly accounts receivable year-on-year change?
What is Dr Reddys Laboratories Limited annual accounts receivable?
The current annual accounts receivable of RDY is $962.85 M
What is the all time high annual accounts receivable for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual accounts receivable is $962.85 M
What is Dr Reddys Laboratories Limited annual accounts receivable year-on-year change?
Over the past year, RDY annual accounts receivable has changed by +$79.99 M (+9.06%)
What is Dr Reddys Laboratories Limited quarterly accounts receivable?
The current quarterly accounts receivable of RDY is $1.01 B
What is the all time high quarterly accounts receivable for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly accounts receivable is $1.01 B
What is Dr Reddys Laboratories Limited quarterly accounts receivable year-on-year change?
Over the past year, RDY quarterly accounts receivable has changed by +$170.22 M (+20.31%)